• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

pipeline

Takeda
Pharma

JPM25: Takeda touts 6 pipeline assets with big sales potential

At JPM, Takeda CEO Christophe Weber said the company is focused on six pipeline assets that could each reel in blockbuster-level sales down the line.
Fraiser Kansteiner Jan 15, 2025 3:17pm
Boehringer Ingelheim global head of BD and licensing Ioannis Sapountzis

Boehringer Ingelheim preps for 2 upcoming oncology launches

Jun 10, 2024 8:20am
Boehringer Ingelheim Boehringer

Boehringer Ingelheim plots 25 new launches over the next decade

Apr 16, 2024 4:30am
Pfizer

Pfizer eyes 8 blockbuster cancer drugs in new oncology plan

Feb 29, 2024 5:42pm
Biogen

Biogen drops Aduhelm efforts after ill-fated accelerated approval

Jan 31, 2024 8:35am
Pfizer CEO Albert Bourla

Pfizer gears up for 'pivotal' 2023, CEO says

Oct 20, 2022 8:19am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings